These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000305-21 A randomized, placebo-controlled, double-blind, six-arm, dose escalation, multi-center study to evaluate the efficacy and safety of SLV306: 150, 300, 600 mg once daily, 150-300 mg twice daily and amlo... 2006-09-05 due-trials
Ongoing 2004-000346-21 A Multi-center, Double-Blind,Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety of Intravenous Tedisamil Sesquifumarate in the Rapid Conversion to Normal Sinus R... not-yet-due
Completed, but no date 2004-000442-21 A randomized, placebo-controlled, double-blind, multi-center, parallel group, single dose study to evaluate cardiac hemodynamics and safety during right heart catheterization of three iv doses of SLV3... bad-data
Ongoing 2004-000703-18 A multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan respectively Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure level... not-yet-due
Completed, but no date, and reported results 2004-002225-45 Randomized, endpoint-blind, parallel group study to demonstrate the serological non-inferiority of the virosomal influenza vaccine Invivac® to the conventional subunit influenza vaccine Influvac® and ... bad-data
Completed, but no date 2004-005012-80 Double-blind, multicenter, randomized, placebo-controlled, parallel-group study to investigate the effect of Creon 25 000 Minimicrospheres on body mass index (BMI) in patients after gastrectomy. bad-data
Completed, but no date, and reported results 2005-000341-11 Immunogenicity and reactogenicity of the trivalent virosomal influenza vaccine Invivac® for the season 2005/2006. An open, baseline controlled study in two groups of healthy subjects: adult subjects a... bad-data
Completed, but no date Terminated 2005-002432-10 A multicenter, randomized, double-blind, placebo-controlled, ascending dose, parallel group study exploring effects of SLV308 up to 42 mg/day administered as an adjunctive therapy to l-dopa in patient... bad-data
Reported results 2005-002654-21 A long-term health economics study of intraduodenal levodopa (Duodopa®) in routine care for patients with advanced idiopathic Parkinson’s disease with severe motor fluctuations and hyper-/dyskinesia. 2011-04-21 due-trials
Not reported Terminated 2005-003475-20 A Randomized, Double-Blind, Placebo-Controlled, Efficacy, Safety and Tolerability Study of Bifeprunox in the Treatment of Elderly Subjects with Psychosis and Behavioural Disturbances Associated with D... 2008-02-25 due-trials
Completed, but no date, and reported results 2005-003791-38 Immunogenicity and reactogenicity of the trivalent virosomal influenza vaccine Invivac® for the season 2005/2006. An open, baseline controlled study in two groups of healthy subjects: adult subjects a... bad-data
Reported results 2005-004854-29 One week double-blind, randomized, placebo-controlled, parallel-group, multi-center study with Creon 25.000 Minimicrospheres in subject with pancreatic exocrine insufficiency after pancreatic surgery,... 2011-07-01 due-trials
Not reported 2005-006033-32 A Randomized, Double-blind, Placebo Controlled Parallel-group Fixed and Flexible SLV308 Dose Arm Study to Assess Efficacy and Safety of SLV308 Monotherapy in the Treatment of Patients with Early Stage... 2007-12-15 due-trials
Reported results 2006-000678-57 A multicenter, randomized, double blind, parallel-group placebo and pramipexole controlled study to assess efficacy and safety of SLV308 monotherapy in the treatment of patients with early stage Parki... 2008-03-14 due-trials
Not reported 2006-000858-45 An open label SLV308 safety extension to study S308.3.001 in early PD patients. 2008-07-07 due-trials
Reported results 2006-000859-18 An open label SLV308 safety extension to study S.308.3.003 in early PD patients 2008-10-12 due-trials
Ongoing 2006-001300-37 Immunogenicity and reactogenicity of the trivalent influenza subunit vaccine Influvac® for the season 2006/2007. An open, baseline-controlled study in two groups of healthy subjects: adult subjects gr... not-yet-due
Ongoing 2006-001301-28 Immunogenicity and reactogenicity of the trivalent virosomal influenza vaccine Invivac® for the season 2006/2007. An open, baseline-controlled study in two groups of healthy subjects: adult subjects g... not-yet-due
Not reported 2006-004972-11 A multi-center, open-label, parallel-group, randomized, flexible dose study to evaluate the safety and tolerability of switching from existing atypical antipsychotics to bifeprunox in subjects with sc... 2008-03-24 due-trials
Not reported Terminated 2006-004973-83 A Randomized, Multicenter, Double-blind, Parallel Group Study To Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients. 2008-04-24 due-trials
Not reported 2006-005182-20 A multicenter, randomized, double-blind, placebo-controlled, parallel group study of SLV308 as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations. 2008-06-23 due-trials
Not reported 2006-005183-91 An open label SLV308 safety extension to study S308.3.002 in patients with Parkinson’s disease experiencing motor fluctuations. 2009-07-07 due-trials
Reported results 2006-005186-18 Open-Label, 6-12 Months Safety and Efficacy Study of Levodopa – Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations 2012-09-20 due-trials
Reported results 2007-000375-42 A multi-center, double-blind, parallel-design, randomized, placebo-controlled, dose-ranging study to assess the efficacy and safety of oral recombinant microbial lipase (SLV339) in subjects with pancr... 2009-03-05 due-trials
Listed as ongoing, but also has a completion date 2007-000490-40 Randomised, Double-Blind, Placebo-Controlled, Multi-Center, Sequential Cohort Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects with Cong... 2008-03-31 bad-data
Reported results 2007-000875-40 Immunogenicity and reactogenicity of the trivalent influenza subunit vaccine Influvac® for the season 2007/2008. An open, baseline-controlled multi-centre study in two groups of healthy subjects: Adu... 2007-08-08 due-trials
Not reported 2007-001095-36 The Van Gogh Study: A Multicenter, Randomized, Double-blind, Parallel-group, Placebo and Pramipexole Controlled Study to Assess Efficacy and Safety of SLV308 as Adjunct Therapy to L-dopa in Patients w... 2008-04-24 due-trials
Not reported 2007-001096-10 An Extension of the Van Gogh Study: An Open Label SLV308 Safety Extension to Study S308.3.004 in Patients with Parkinson’s Disease Experiencing Motor Fluctuations 2008-04-24 due-trials
Reported results 2007-001921-86 A double-blind, placebo-controlled, parallel-group, multi-center study to investigate the effect of Omacor (n-3 PUFA) on lipid parameters in HIV infected patients treated with HAART 2008-12-18 due-trials
Reported results 2007-004004-12 A STUDY TO INVESTIGATE THE EFFECT OF PANCRELIPASE DELAYED RELEASE CAPSULES ON MALDIGESTION IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CHRONIC PANCREATITIS AND PANCREATECTOMY 2009-02-11 due-trials
Not reported Terminated 2008-000400-81 A Multicenter, Randomized, Double Blind, Pramipexole Controlled Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients with Parkinson’s Dise... 2011-05-31 due-trials
Reported results 2008-001038-28 Immunogenicity, Reactogenicity and Safety of the Trivalent Influenza Subunit Vaccine Influvac® for the Season 2008/2009. An Open-Label, Baseline-Controlled Multi-Center Study in Two Groups: Adult Subj... 2008-07-17 due-trials
Reported results 2008-001409-40 A Randomized, Double blind, Placebo-Controlled Dose Escalation Study to Investigate the Safety and Pharmacokinetics after Single and Multiple Doses of SLV334 in Sequential Cohorts of Patients with Mod... 2010-08-16 due-trials
Reported results 2008-003786-20 A Double-Blind, Placebo-Controlled, Randomized, Multi-Center, Dose-Finding Study of SLV320, a Selective A1 Adenosine Receptor Antagonist, to Evaluate the Effect on Renal Function and Safety in Subject... 2010-01-04 due-trials
Ongoing 2008-004943-12 The Rubens Study: A Multicenter, Randomized, Double-blind, Parallel Group, Placebo and Pramipexole Controlled Study to Explore the Efficacy, Tolerability and Safety of Different Doses and Titration Sc... not-yet-due
Completed, but no date Terminated 2008-005993-12 A three month double-blind, randomized, placebo-controlled, parallel group, multi-center study with Creon® 25.000 MMS? in subjects after an attack of acute pancreatitis suffering from pancreatic exocr... bad-data
Reported results 2009-010900-27 Immunogenicity, reactogenicity and safety of the trivalent influenza subunit vaccine Influvac® for the season 2009/2010. An open-label, baseline-controlled multi-center study in two groups: adult subj... 2009-07-09 due-trials

Related organisations

Over time organisations can merge, or split.

We think Solvay Pharmaceuticals is now effectively part of Abbvie.